🇺🇸 FDA
Pipeline program

Green Tea Extract

2018H0592

Unknown other completed

Quick answer

Green Tea Extract for Dysbiosis is a Unknown program (other) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
Dysbiosis
Phase
Unknown
Modality
other
Status
completed

Clinical trials